Blue Jet Healthcare Limited (BLUEJET.NS)
Blue Jet Healthcare Limited operates in the Biotechnology industry of the Healthcare sector, headquartered in Thane, MA, IN. The stock last traded at $584.50, down 1.70% on the session, giving a market capitalisation of $101.39B. Its beta of 0.64 implies it has historically moved less than the broad market.
Blue Jet Healthcare Ltd. is a company that focuses on the manufacturing and supply of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), which are critical components for the pharmaceutical and healthcare sectors. Its product offerings include integrated intermediates used in contrast media, saccharin and its associated salts, and a range of specialized pharmaceutical intermediates and APIs. The company also delivers comprehensive contract development and manufacturing (CDMO/CMO) and development services. Founded in 1968, Blue Jet Healthcare is headquartered in Thane, India, and maintains a broad international operational footprint across countries such as India, Norway, the United States, Sweden, Italy, and Spain.
Blue Jet Healthcare Limited is most often compared with the following Healthcare names: